Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants.

Authors:
Hirabidian M; Bocket L; Demaret J; Vuotto F; Rabat A and 5 more

Journal:
J Clin Virol

Publication Year: 2022

DOI:
10.1016/j.jcv.2022.105268

PMCID:
PMC9383946

PMID:
35998394

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Clin Virol

Abbreviation: J Clin Virol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Virology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical utility of SARS-CoV-2 subgenomic RT-PCR in a pediatric quaternary care setting.
Osborn LJ; Chen PY; Flores-Vazquez J and 6 more (2023) - Transparency Score: 3/6
Correlation between monkeypox viral load and infectious virus in clinical specimens.
Lim CK; McKenzie C; Deerain J and 6 more (2023) - Transparency Score: 3/6
Effect of non-pharmaceutical interventions on the incidence of respiratory viruses at a tertiary ca…
Clark B; Cintron M; Kamboj M and 1 more (2023) - Transparency Score: 3/6
Evaluation of a multiplexed oligonucleotide ligation assay for SARS-CoV-2 variant identification.
Solis D; Sibai M; Kung F and 8 more (2023) - Transparency Score: 2/6
Evaluation of four laboratory-based high-throughput SARS-CoV-2 automated antigen tests compared to …
Leineweber TD; Ghathian K; Lisby JG and 15 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding AirDiag company (www.air-diag.fr) provided kits for ichroma™ COVID-19 nAb testing. The MONITOCOV study was supported by the French government through the Programme Investissement d'Avenir (I-SITE ULNE/ANR-16-IDEX-0004 ULNE) managed by the Agence Nationale de la Recherche. The funders had no role in the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025